logo
Delistings mount amid poor trading liquidity

Delistings mount amid poor trading liquidity

The Star05-05-2025

SINGAPORE: Four Singapore Exchange (SGX) companies announced privatisation offers last week, taking the number of companies that have received such offers in 2025 to at least 11.
While most of the companies received offers from major shareholders citing poor trading liquidity as the main reason for privatisation, one firm – gaming hardware distributor Ban Leong Technologies – received an offer last week from a third-party acquirer with no prior relationship to the company.
Singapore gaming company Epicsoft Asia, a wholly owned subsidiary of Nasdaq-listed gaming giant GCL Global, on April 30 made an offer to take Ban Leong private for 60.29 Singapore cents a share in cash.
The offer price represents a premium of 60.8% over Ban Leong's last transacted share price of 37.5 cents before the offer was made.
GCL Global's chief executive Sebastian Toke said that the company sees strong strategic value in acquiring Ban Leong, citing its distribution strength in South-East Asia and growth in commercial and eCommerce segments as qualities not fully reflected in its share price.
'Both Epicsoft Asia and Ban Leong are born and bred Singapore firms with a strong presence in interactive entertainment software and gaming-related hardware, respectively, in Asia,' Toke said.
'The acquisition would combine the strengths of both companies in ways that would enable GCL to expand its global strategy in developing and marketing differentiated gaming products.'
Epicsoft Asia has already received irrevocable undertakings to accept the offer from Ban Leong's managing director Ronald Teng Woo Boon and his wife Teo Su Ching, who together hold 28.13% of the company.
If Epicsoft Asia secures at least 90% of Ban Leong's issued shares at the close of its offer, it can compulsorily buy the remaining shares at the same offer price from shareholders who have not accepted the offer.
Shares of Ban Leong jumped by more than 57% to close the week at 59 cents, their highest level since the company listed in June 2005.
The proposed acquisition of Ban Leong underscores the disconnect between public market valuations on SGX and the underlying strengths of many listed companies.
Despite demonstrating strong performance and growth potential, firms like Ban Leong remain undervalued, largely due to low trading liquidity and limited market visibility.
This valuation gap is attracting buyers like GCL Global, who are willing to pay a premium for quality assets that the market has overlooked.
It also raises questions about how SGX can better support fairer valuations and stem the pace of delistings, which has been accelerating.
In 2025 so far, at least nine companies have announced potential delistings.
They are SLB Development, PEC, Econ Healthcare, Sinarmas Land, ICP, Amara Holdings, Procurri Corp, Aoxin Q&M and Ban Leong.
The privatisation offers for Amara, Procurri Corp, Aoxin Q&M and Ban Leong all took place last week.
Amara, which received an offer from its bosses and developers Wing Tai and Hwa Hong, has already secured irrevocable undertakings from chairman Albert Teo and his family, who collectively hold 90.58% of Amara.
Meanwhile, shareholders of Japfa and Paragon Real Estate Investment Trust have since accepted offers to be taken private. The companies will be delisted from the SGX.
In contrast, just one company, automotive group Vin's Holdings, has listed on the SGX so far. A second company, candy maker YLF Group Marketing, called off its planned initial public offering in April.
The pace of potential delistings also appears to be accelerating, compared with the previous year. In 2024, a total of 20 companies delisted from the Singapore bourse, while four new companies went public.
Two companies saw their shares dive last week, one of which was CapitaLand Investment (CLI), a constituent of the Straits Times Index (STI).
Shares of the property fund manager dropped 8% to S$2.53 on May 2 after trading ex-dividend.
This is the cut-off date when buying the stock no longer entitles investors to receive the next dividend payout.
CLI has declared a 2024 dividend of 12 cents a share, unchanged from 2023's payout, on May 13.
CLI on April 30 also announced poorer revenues for the first quarter of 2025 after excluding contributions from CapitaLand Ascott Trust (Clas) from its financial results.
Revenue amounted to S$496mil for the quarter ended March 31, representing a 24% year-on-year decline due to the deconsolidation of Clas.
In December 2024, CLI sold a 4.9% stake in Clas for S$162mil to an unrelated party, resulting in Clas no longer qualifying as its subsidiary.
Shares of iFast dropped by more than 11% during the week, closing on May 2 at S$6.30 despite announcing that its global trust, a Singapore-incorporated entity within the group, had been granted a trust business licence by the Monetary Authority of Singapore.
This will enable iFast to expand its wealth management capabilities by supporting clients across the entire wealth life cycle, from accumulation and growth to preservation and legacy planning, iFast said.
Still, the move failed to offset share price declines earlier in the week, when iFast on April 28 cut the 2025 profit before tax target for its Hong Kong operations to HK$380mil from its previous guidance of HK$500mil.
UOB, DBS Bank and OCBC Bank are scheduled to release their 2025 first quarter business updates on May 7, May 8 and May 9, respectively.
The three banks, which experienced price declines averaging 8% in April, now account for 51% of the STI.
Institutional investors sold over S$700mil worth of shares in the three banks in April, according to SGX data.
In contrast, retail investors ploughed S$1.58bil into the three stocks during the month, the data showed. — The Straits Times/ANN

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stocks, dollar climb as investors hope for US-China trade talk progress
Stocks, dollar climb as investors hope for US-China trade talk progress

New Straits Times

time35 minutes ago

  • New Straits Times

Stocks, dollar climb as investors hope for US-China trade talk progress

SINGAPORE: Global stocks rose and the dollar edged higher on Tuesday as trade talks between the United States and China were set to extend to a second day, with tentative signs that tensions between the world's two largest economies could be easing. Following Asia's lead, EUROSTOXX 50 futures and FTSE futures both edged up roughly 0.1 per cent each, while Nasdaq and S&P 500 futures in the US were also gearing up for a higher open. US President Donald Trump put a positive spin on the talks, which wrapped up for the night on Monday and were set to resume on Tuesday. Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick and US Trade Representative Jamieson Greer were set to meet for the second day with their Chinese counterparts. Any progress in the negotiations is likely to provide relief to markets given that Trump's often shifting tariff announcements and swings in Sino-US ties have undermined the world's two biggest economies, disrupted supply chains and threaten to hobble global growth. Stocks advanced in Asia, with MSCI's broadest index of Asia-Pacific shares outside Japan advancing 0.7 per cent to hit their highest since January 2022. "While market participants are clearly taking a glass half-full view of the outlook, both on trade policy and more broadly, we don't think that should be interpreted as a view that tariffs will be fully unwound," said Jonas Goltermann, deputy chief markets economist at Capital Economics. Goltermann anticipates US duties on Chinese goods to settle at around 40 per cent, while most analysts have said that the universal 10 per cent levy on imports into the United States is here to stay. In Tokyo, attention was on the measures the Japanese government was considering to calm recent bond (JGB) market volatility. Finance Minister Katsunobu Kato said policymakers were looking at measures to promote domestic ownership of Japanese government bonds, a day after Reuters reported that Japan is considering buying back some super-long government bonds issued in the past at low interest rates. The yield on the 10-year JGB fell one basis point to 1.46 per cent, while the 30-year yield slid three bps to 2.88 per cent early in the session. Yields on super-long JGBs rose to record levels last month due to dwindling demand from traditional buyers such as life insurers, and jitters over steadily rising debt levels globally. "The volatility at the super-long segment of the curve stems from a supply-demand imbalance that has been brewing since the BOJ embarked on balance sheet normalisation," said Justin Heng, APAC rates strategist at HSBC Global Investment Research. In currencies, the dollar attempted to regain its footing after falling on Monday. Against the yen, the dollar was up 0.19 per cent to 144.83. The euro fell 0.17 per cent to US$1.14 while sterling slipped 0.07 per cent to US$1.3537. Trump's erratic trade policies and worries over Washington's growing debt pile have dented investor confidence in US assets, in turn undermining the dollar, which has already fallen more than eight per cent for the year. INFLATION TEST The next test for the greenback will be on Wednesday, when US inflation data comes due. Expectations are for core consumer prices to have picked up slightly in May, which could push back against bets of imminent Federal Reserve rate cuts. The producer price index (PPI) report will be released a day later. "May's US CPI and PPI data will be scrutinised for signs of lingering inflationary pressures," said Convera's FX and macro strategist Kevin Ford. "If core CPI remains elevated, expectations for rate cuts could be pushed beyond the June 18 FOMC meeting." Traders see the Fed keeping rates on hold at its policy meeting next week, but have priced in roughly 44 bps worth of easing by December. In commodity markets, oil prices were marginally higher, with US West Texas Intermediate crude close to a more than two-month high hit earlier in the session. Spot gold fell 0.5 per cent to US$3,310.17 an ounce.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders

Malaysian Reserve

timean hour ago

  • Malaysian Reserve

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders

NEW YORK, June 9, 2025 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Old Point Financial Corporation (NASDAQ: OPOF)'s sale to Hampton Roads based TowneBank. Under the terms of the agreement, Old Point shareholders will elect to receive either $41.00 in cash or 1.1400 shares of TowneBank common stock for each share of Old Point common stock. If you are an Old Point shareholder, click here to learn more about your rights and options. ProAssurance Corporation (NYSE: PRA)'s sale to The Doctors Company for $25.00 in cash per share. If you are a ProAssurance shareholder, click here to learn more about your rights and options. SpringWorks Therapeutics, Inc. (NASDAQ: SWTX)'s sale to Merck KGaA, Darmstadt, Germany for $47.00 per share in cash. If you are a SpringWorks shareholder, click here to learn more about your rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@ or zhalper@ Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information:Halper Sadeh LLCDaniel Sadeh, Halper, Esq.(212) 763-0060sadeh@

Ispire Malaysia denies domestic vape sales, reaffirms export-only operations
Ispire Malaysia denies domestic vape sales, reaffirms export-only operations

New Straits Times

time3 hours ago

  • New Straits Times

Ispire Malaysia denies domestic vape sales, reaffirms export-only operations

KUALA LUMPUR: Nasdaq-listed Ispire Technology Inc's subsidiary, Ispire Malaysia Sdn Bhd, has clarified that all its vaporiser hardware manufacturing activities are strictly for export purposes, amid public scrutiny and recent reports suggesting otherwise. In a statement, Ispire emphasised it manufactures only semi-finished hardware devices and does not handle any nicotine or cannabis substances in Malaysia, with all production shipped abroad and not marketed or sold domestically. "We take this matter seriously and strictly adhere to all regulatory and licensing requirements, including the Control of Smoking Products for Public Health Act 2024 (Act 852). "These products do not contain any nicotine or cannabis – liquids or gels – and thus are not subject to the Health Ministry regulations under the Act 852," it said in a statement released this week. The clarification follows after recent articles reported Ispire had received Malaysia's first federal nicotine manufacturing licence in May. The development raised questions among lawmakers and the public, particularly due to vape product sales remain banned in several Malaysian states, including Johor. The Health Ministry (MOH) responded by confirming that the licence, issued by the Investment, Trade and Industry Ministry through the Malaysian Investment Development Authority, does not equate to permission to sell vape products locally. "The MOH has never approved any registration for the product for the local market. Any party intending to import, produce, or distribute smoking products locally must apply for product registration with the ministry." Ispire is involved in the research and development, design, sales, commercialisation, marketing, and distribution of vaping products and its own branded e-cigarettes. The interim licence granted to Ispire allows it to commence production of its products in Johor, which has banned vape sales since 2016. Ispire said its operations fully comply with all Malaysian laws and that any production involving nicotine would only occur upon approval from both state and federal regulators and will remain strictly for export. The company also highlighted its innovations in consumer protection technologies, including a blockchain-based age-gating system and geo-fencing technology to prevent underage or unauthorised usage. The Johor plant currently operates seven production lines, with plans to expand up to 80 lines following final regulatory approvals. The US$50 million investment into the Johor facility forms part of Ispire's strategic relocation of manufacturing from China to Malaysia to serve international markets such as the United States and the United Kingdom. "Our Malaysian operations focus exclusively on vaporiser hardware production, which is shipped empty for export only, with no nicotine or cannabis substances at any stage of the manufacturing process," it concluded.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store